BHLHE40 and Alzheimer disease: Finally, we validated these bioinformatic findings experimentally in human and mouse macrophages/microglia, nominating BHLHE40/41 as candidate transcriptional regulators of the DLAM response and putative drug targets for therapeutic modulation of macrophage/microglial function in AD and other disorders of lipid-rich tissues.